MENU
  • Home
  • About Us
    • Our Core Values
    • Company Information
    • Founder’s Message
  • People
    • CEO: Hiro Kimura, Ph.D., R.Ph.
    • Advisors
      • Tom Curran, Ph.D., FRS
      • Joe Bolen, Ph.D.
      • Guanghui Hu, Ph.D.
      • Karuppiah Kannan, Ph.D.
  • Business
    • BNCT Project 1102
    • NewXus Fund
  • News & Article
  • Contact Us
  • JP
Bloom X³
Empowering Life Science for Blooming Life
  • Home
  • About Us
    • Our Core Values
    • Company Information
    • Founder’s Message
  • People
    • CEO: Hiro Kimura, Ph.D., R.Ph.
    • Advisors
      • Tom Curran, Ph.D., FRS
      • Joe Bolen, Ph.D.
      • Guanghui Hu, Ph.D.
      • Karuppiah Kannan, Ph.D.
  • Business
    • BNCT Project 1102
    • NewXus Fund
  • News & Article
  • Contact Us
  • JP
  • Home
  • About Us
  • People
  • Business
  • News & Article
  • Contact Us
  • JP
  1. Home
  2. 2025年
  3. September

September 2025– date –

  • Activity

    Press Release: Hiro Kimura, Ph.D., R.Ph., Founder & CEO of Bloom X³ (formerly The Global Blooming), has been officially selected as an awardee of the “Tokyo Emerging VC Fund Accelerator ” co-hosted by the Japan External Trade Organization (JETRO, under the Ministry of Economy, Trade and Industry of Japan) and Coolwater Capital.

    This prestigious international accelerator program supports the development of next-generation venture capital leaders from Japan and promotes the creation of globally connected VC funds. Dr. Kimura’s selection reflects his outstanding t...
    September 9, 2025
  • Activity

    Our New Name — Bloom X³

    From Seed to Bloom. Synergy to the third power —Bloom X³ Today we become Bloom X³.Our purpose is simple and firm: every Seed we touch must bloom. By multiplying R&D × Business × Investment, we create a unique arena where transformati...
    September 9, 2025
1

最近の投稿

  • Bloom X³ Founder & CEO Hiro Kimura Participated in Coolwater Capital’s Investor Summit and Strengthened US Engagement in San Francisco
  • Research Collaboration with Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, Enters Phase 2 — The 1102 Program Toward Aging, Rejuvenation, and Regenerative Medicine
  • Bloom X³ News:Congratulations to Dr. Joe Bolen and Orna Therapeutics on the Acquisition by Eli Lilly
  • Meeting with Nobel Laureate Prof. Shinya Yamanaka
  • Invited Talk at ASDRP: “Research vs. Business—How to Navigate Career Inflection Points”

最近のコメント

No comments to show.

アーカイブ

  • May 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • September 2025
  • August 2025
  • June 2025
  • May 2025

カテゴリー

  • Activity
  • Article
  • News
  • Home
  • Privacy Policy
  • Terms of Use
  • Contact Us

© Bloom X³

  • Menu
  • Home
  • Privacy Policy
  • Terms of Use
  • Contact Us